Virological Response to a Triple Nucleoside/nucleotide Analogue Regimen over 48 Weeks in HIV-1-infected Adults in Africa
P. Kaleebu,D. Pillay,A. S. Walker,V. Robertson, C. V. Gale, R. Enzama,D. Yirrell,F. Lyagoba,C. Kityo,P. Munderi,A. Reid,D. M. Gibb, D. Bray, A. Burke,M. Ait-Khaled,J. H. Darbyshire, P. Muygenyi,J. Hakim,H. Grosskurth,C. Gilks,S. Tugume,M. Chirara, C. Gale,P. Mugyenyi,F. Ssali,D. Tumukunde, T. Otim,L. Namale, A. Mukose, A. Muhwezi,G. Kabuye, G. Mulindwa,D. Atwine,H. Kyomugisha, A. Drasiku, C. Tumusiime, J. Sabiiti, C. Zawedde, J. Komugyena, J. Okiror,R. Byaruhanga, P. Ocitti, T. Bakainyaga Grace,H. Katabira, G. Barungi, D. Masiira, A. Atwine,S. Murungi, J. Tukamushaba, L. Mugarura, P. Mwesigwa, A. Latif, A. Jamu, S. Makota, T. Mupudzi,G. Musoro, N. Ngorima, M. Pascoe,F. Taziwa,L. Chakonza,E. Chidziva, H. Chirairo, S. Chitsungo,F. Mapinge, A. Mawora,C. Muvirimi, G. Tinago, J. Chimanzi,J. Machingura, C. Maweni,S. Mutsai, R. Warara, M. Matongo, N. Mdege,S. Mudzingwa, M. Jangano, I. Machingura, K. Moyo, L. Vere, E. Chigwedere,M. Phiri, K. Wangati, H. Byomire,B. Amuron,D. Nsibambi,R. Kasirye,E. Zalwango, M. Nakazibwe,B. Kikaire, G. Nassuna, R. Massa,M. Aber, M. Namyalo, A. Zalwango, L. Generous,P. Khauka, N. Rutikarayo, W. Nakahima,A. Mugisha,J. Nakiyingi-Miiro,P. Hughes,E. Katabira, J. Oyugi, A. Ronald, A. Kambungu, J. Martin,R. Nalumenya, R. Nairubi, E. Bulume, M. Teopista,C. Twijukye, F. Sematala,H. Byakwaga,A. Coutinho, B. Etukoit, K. Boocock, C. Puddephatt, D. Winogron,J. Darbyshire,A. Babiker,H. Wilkes,M. Rauchenberger,S. Sheehan,L. Peto, K. Taylor,I. Weller, S. Bahendeka, M. Bassett,A. Chogo Wapakhabulo,B. Gazzard,O. Mugurungi, E. Loeliger,J. Leith, P. Naidoo, M. Palmer,J. Rooney,J. -M. Steens,A. McLaren, C. Hill,J. Matenga,A. Pozniak,D. Serwadda AIDS（2006）
Key words
antiretroviral therapy,Africa,nucleoside/nucleotides
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper